
- BioPharm International's BP Elements, March 2023
- Volume 2
- Issue 3
iotaSciences Launches Single-Cell Picker
iotaSciences isoPick is designed to expand handling solutions for cell biology and gene therapy applications.
iotaSciences, a spin-out from Oxford University specializing in single-cell handling solutions, announced completion of its new single-cell picker instrument on Feb. 6, 2023. The isoPick is designed to provide temperature-controlled handling of single cells during isolation, as well as picking through a workflow guided by touchscreen interfaces.
According to a company press release, the isoPick is intended for cell and gene therapy researchers, as well as the wider single-cell research community, as a means of providing verifiable isolation of single cells with high cell viability and stable single-cell outgrowth. Like the company's other instruments, it is designed to have a small footprint instrument that requires minimal maintenance.
Source:
Articles in this issue
over 2 years ago
Evolutions in Vaccine Developmentover 2 years ago
Advances in In Vivo CAR T-cell Therapiesover 2 years ago
FDA Issues Guidance on Potency for mAbs and Therapeutic Proteinsover 2 years ago
Charles River Launches Novel IgY-based ELISA KitNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.